Roden’s research lauded by Heart Rhythm Society
Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, has been named to receive the Heart Rhythm Society’s Douglas P. Zipes Lectureship Award.
Dan Roden, M.D.
He presented the lecture “Heart to Heart: Treating Arrhythmias Using Personalized Medicine” on May 9 at the society’s 33rd annual Scientific Sessions in Boston.
Roden received his medical degree and training in Internal Medicine from McGill University in Montreal and then trained at Vanderbilt in Clinical Pharmacology and Cardiology.
His career-long focus has been studies of the clinical, genetic, cellular and molecular basis of arrhythmia susceptibility and variability responses to arrhythmia therapies, and he is widely recognized for his expertise in drug-induced arrhythmias.
Over the last 10 years, he has also led Vanderbilt’s broader efforts in pharmacogenomics discovery and implementation.
Roden is principal investigator for the Vanderbilt sites of the National Institutes of Health’s Pharmacogenomics Research Network (where he currently serves as chair of the steering committee) and the National Human Genome Research Institute’s Electronic Medical Records and Genomics Network. He directs BioVU, the Vanderbilt DNA databank that currently links DNA samples from more than 135,000 patients to de-identify electronic medical records.
Roden has served as director of the Vanderbilt Arrhythmia Service and director of the Division of Clinical Pharmacology (1992-2004).
The lectureship is named for Zipes, a Distinguished Professor of Medicine, Pharmacology and Toxicology at Indiana University and director of the Cardiology division and Krannert Institute of Cardiology.